ABCG2 and ABCB1 efflux drug transporter expression andsingle nucleotide variations (SNVs) in patients on tamoxifen therapy

被引：0
|
作者：
Wong, Michelle [1 ]
Medwid, Samantha [1 ]
Kim, Richard [1 ,2 ,3 ]
机构：
[1] Western Univ, London, ON, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Lawson Hlth Res Inst, London, ON, Canada
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2024年 / 102卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：37
相关论文
共 50 条
  • [21] ABCB1 and ABCG2 Drug-Efflux Transporters Function and Its Association with Disease Activity in a Cohort of Patients with Rheumatoid Arthritis
    Atisha-Fregoso, Yemil
    Fragoso-Loyo, Hilda
    Jakez-Ocampo, Juan
    Lima, Guadualupe
    Banos, Miguel
    Pascual-Ramos, Virginia
    Contreras-Yanez, Irazu
    Llorente, Luis
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S175 - S175
  • [22] Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo
    Lin, Fan
    Hoogendijk, Lisette
    Buil, Levi
    Beijnen, Jos H.
    van Tellingen, Olaf
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (08) : 2059 - 2064
  • [23] Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib
    Akimitsu Maeda
    Hitoshi Ando
    Kei Irie
    Naoya Hashimoto
    Jun-ichi Morishige
    Shoji Fukushima
    Akira Okada
    Hiromichi Ebi
    Masahide Matsuzaki
    Hiroji Iwata
    Masataka Sawaki
    European Journal of Clinical Pharmacology, 2022, 78 : 1239 - 1247
  • [24] Lipid Regulation of the ABCB1 and ABCG2 Multidrug Transporters
    Hegedus, Csilla
    Telbisz, Agnes
    Hegedus, Tamas
    Sarkadi, Balazs
    Ozvegy-Laczka, Csilla
    ABC TRANSPORTERS AND CANCER, 2015, 125 : 97 - 137
  • [25] Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib
    Maeda, Akimitsu
    Ando, Hitoshi
    Irie, Kei
    Hashimoto, Naoya
    Morishige, Jun-ichi
    Fukushima, Shoji
    Okada, Akira
    Ebi, Hiromichi
    Matsuzaki, Masahide
    Iwata, Hiroji
    Sawaki, Masataka
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (08) : 1239 - 1247
  • [26] What next? Preferably development of drugs that are no longer transported by the ABCB1 and ABCG2 efflux transporters
    van Hoppe, Stephanie
    Schinkel, Alfred H.
    PHARMACOLOGICAL RESEARCH, 2017, 123 : 144 - 144
  • [27] The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib
    Loos, Nancy H. C.
    Sparidans, Rolf W.
    Heydari, Paniz
    Bui, Viet
    Lebre, Maria C.
    Beijnen, Jos H.
    Schinkel, Alfred H.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 485
  • [28] Karanjin interferes with ABCB1, ABCC1, and ABCG2
    Michaelis, Martin
    Rothweiler, Florian
    Nerreter, Thomas
    Sharifi, Mohsen
    Ghafourian, Taravat
    Cinatl, Jindrich, Jr.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (01): : 92 - 105
  • [29] ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells
    Svirnovski, Arcadi I.
    Shman, Tatsiana V.
    Serhiyenka, Tatsiana F.
    Savitski, Valery P.
    Smolnikova, Victoria V.
    Fedasenka, Uladzimir U.
    HEMATOLOGY, 2009, 14 (04) : 204 - 212
  • [30] Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development
    Sawicki, Wojciech T.
    Kujawa, Marek
    Jankowska-Steifer, Ewa
    Mystkowska, Ewa T.
    Hyc, Anna
    Kowalewski, Cezary
    GENE EXPRESSION PATTERNS, 2006, 6 (07) : 738 - 746
12345